Cyclophosphamide (CY), the agent with cytoreductive activity, is widely exploited in cancer chemotherapy, and can be used alone or in combination with various cytokines and growth factors to stimulate the egress of hematopoietic stem/progenitor cells (HSPC) from the BM compartment. The aim of the present study was to exam the morphology and ultrastructure of the bone marrow, spleen and liver of mice injected intraperitoneally with a single dose of cyclophosphamide (200 mg/kg bw) and the localization of cells expressing markers of early hematopoietic cells in studied organs and the peripheral blood. We observed that the CY-induced morphological changes in the BM and spleen were reconstructed on day 4. of experiment, and the spleen was repopu...
We report that hematopoietic progenitor cells expressing the CD34 antigen (CD34+ cells) transiently ...
Objective: Cyclophosphamide (CPA) is a chemotherapeutic agent, induces hepatotoxicity as one of its ...
We report that hematopoietic progenitor cells expressing the CD34 antigen (CD34 cells) transiently ...
Cyclophosphamide (CY), the agent with cytoreductive activity, is widely exploited in cancer chemothe...
The aim of the study was to examine the morphology of the bone marrow of mice after stimulation with...
The cellular mobilisation of mice with granulocyte colony-stimulating factor (G-CSF) results in an e...
The aim of the work was to examine the morphology of the bone marrow of mice during stimulation with...
Cyclophosphamide is an alkylating agent developed in the 1960s for the use in treatment of cancerous...
Objective. Hematopoietic stem and progenitor cells normally reside in the bone marrow but can be mob...
The goal of the study was to investigate changes in haematopoietic tissues, bone marrow (BM) and spl...
Peripheral blood stem cells (PBSCs) are increasingly used in autologous stem cell transplantations. ...
The synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes...
Objective To explore the effect of the administration time of HS6101 on hematopoietic recovery in IC...
The authors used the competitive repopulation assay and simple statistical analyses to estimate conc...
Hematopoietic progenitor cells (HPCs) normally reside in the bone marrow (BM) but can be mobilized i...
We report that hematopoietic progenitor cells expressing the CD34 antigen (CD34+ cells) transiently ...
Objective: Cyclophosphamide (CPA) is a chemotherapeutic agent, induces hepatotoxicity as one of its ...
We report that hematopoietic progenitor cells expressing the CD34 antigen (CD34 cells) transiently ...
Cyclophosphamide (CY), the agent with cytoreductive activity, is widely exploited in cancer chemothe...
The aim of the study was to examine the morphology of the bone marrow of mice after stimulation with...
The cellular mobilisation of mice with granulocyte colony-stimulating factor (G-CSF) results in an e...
The aim of the work was to examine the morphology of the bone marrow of mice during stimulation with...
Cyclophosphamide is an alkylating agent developed in the 1960s for the use in treatment of cancerous...
Objective. Hematopoietic stem and progenitor cells normally reside in the bone marrow but can be mob...
The goal of the study was to investigate changes in haematopoietic tissues, bone marrow (BM) and spl...
Peripheral blood stem cells (PBSCs) are increasingly used in autologous stem cell transplantations. ...
The synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes...
Objective To explore the effect of the administration time of HS6101 on hematopoietic recovery in IC...
The authors used the competitive repopulation assay and simple statistical analyses to estimate conc...
Hematopoietic progenitor cells (HPCs) normally reside in the bone marrow (BM) but can be mobilized i...
We report that hematopoietic progenitor cells expressing the CD34 antigen (CD34+ cells) transiently ...
Objective: Cyclophosphamide (CPA) is a chemotherapeutic agent, induces hepatotoxicity as one of its ...
We report that hematopoietic progenitor cells expressing the CD34 antigen (CD34 cells) transiently ...